2796 — Pharmarise Holdings Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Pharmarise Holdings, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.
2022 May 31st | 2023 May 31st | 2024 May 31st | 2025 May 31st | 2026 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,322 | 1,049 | 143 | 8 | 698 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 214 | 406 | 731 | 316 | 127 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2,131 | -161 | 671 | -504 | 848 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 713 | 2,518 | 2,715 | 1,313 | 3,278 |
| Capital Expenditures | -466 | -542 | -619 | -702 | -721 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 174 | -161 | -2,501 | -3,760 | -1,254 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -292 | -703 | -3,120 | -4,462 | -1,975 |
| Financing Cash Flow Items | -2 | — | -76 | -3 | -99 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,034 | -1,072 | 2,771 | 939 | -181 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -613 | 743 | 2,366 | -2,210 | 1,122 |